Skip to main content
Fig. 4 | Cancer Nanotechnology

Fig. 4

From: Preferential drug delivery to tumor cells than normal cells using a tunable niosome–chitosan double package nanodelivery system: a novel in vitro model

Fig. 4

ad Images showing cells incubated in presence of chitosan: a, b IOSE-121 normal cells or c, d OV2008 tumor cells incubated for 10 min and 1 h. eh Images showing cells incubated with chitosan/noisome/paclitaxel (0.4 µM) system: e, f IOSE-121 normal cells or g, h OV2008 tumor cells incubated for 10 min and 1 h. Scale bar = 10 µm

Back to article page